Our round-up of developments in the contract research sector includes a fundraising for Ecron Acunova, trial registrations in India a …
Mexico City has announced plans for what it hopes will be a world-class centre for biomedical and nano-medical research.To be …

Norgine has appointed Dr Yvonne Lamb as director, global pharmacovigilance, with effect from January 25 2010. A qualified physician, Yvonne …
Goddard joins BST with nearly 15 years of executive sales, business development and marketing experience from a diverse set of …
Ball joined BioStorage Technologies in 2007, as Vice President of global sales and marketing, and was responsible for leading sales …
The company will increase its existing operation in Indianapolis to include an additional 40,000 square-foot cold-storage facility, in Park Fletcher …
In her new position at BioStorage Technologies, Michael will provide direct, hands-on leadership of sample management operations, including management of …
Benner joined BST in 2003 and spearheaded the creation of the company’s quality assurance department. In her new role, Benner …
Biorepositories 2009 is the only U.S.-based biobanking conference designed specifically for pharmaceutical and biotech companies and will address critical issues …
Since the company’s inception in 2002, Mills has been a driving force at the core of BST’s sales efforts, while …
All CRAs will be seconded via Chiltern’s European Resourcing Solutions team and fully allocated to the company under a Functional …
Dr. Attila Lorinczi will lead this operation. Dr. Lorinczi is a member of the Hungarian Medical Society and the Society …
According to the MHRA, a clinical research facility with standard accreditation can carry out all Phase I trials other than …
Chiltern International Limited (Chiltern), a global Clinical Research Organization (CRO) providing clinical development and staffing services in Europe, the Americas …

Sue Samsonov has joined Woolley Pau as a senior account director.She has over 15 years of advertising and marketing experience, …

Novartis has been given a green light in the European Union to sell its Onbrez respiratory drug, allowing the firm …